BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29621951)

  • 1. Patient-level outcomes and virologic suppression rates in HIV-infected patients receiving antiretroviral therapy in Rwanda.
    Riedel DJ; Stafford KA; Memiah P; Coker M; Baribwira C; Sebeza J; Karorero E; Nsanzimana S; Morales F; Redfield RR
    Int J STD AIDS; 2018 Aug; 29(9):861-872. PubMed ID: 29621951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria.
    Meloni ST; Chang CA; Eisen G; Jolayemi T; Banigbe B; Okonkwo PI; Kanki PJ
    PLoS One; 2016; 11(10):e0164030. PubMed ID: 27764094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.
    Franke MF; Kaigamba F; Socci AR; Hakizamungu M; Patel A; Bagiruwigize E; Niyigena P; Walker KD; Epino H; Binagwaho A; Mukherjee J; Farmer PE; Rich ML
    Clin Infect Dis; 2013 May; 56(9):1319-26. PubMed ID: 23249611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study.
    Nsanzimana S; Semakula M; Ndahindwa V; Remera E; Sebuhoro D; Uwizihiwe JP; Ford N; Tanner M; Kanters S; Mills EJ; Bucher HC
    BMC Infect Dis; 2019 Apr; 19(1):312. PubMed ID: 30953449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.
    Cuong DD; Sönnerborg A; Van Tam V; El-Khatib Z; Santacatterina M; Marrone G; Chuc NT; Diwan V; Thorson A; Le NK; An PN; Larsson M
    BMC Infect Dis; 2016 Dec; 16(1):759. PubMed ID: 27986077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda.
    Rich ML; Miller AC; Niyigena P; Franke MF; Niyonzima JB; Socci A; Drobac PC; Hakizamungu M; Mayfield A; Ruhayisha R; Epino H; Stulac S; Cancedda C; Karamaga A; Niyonzima S; Yarbrough C; Fleming J; Amoroso C; Mukherjee J; Murray M; Farmer P; Binagwaho A
    J Acquir Immune Defic Syndr; 2012 Mar; 59(3):e35-42. PubMed ID: 22156912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda.
    Elul B; Basinga P; Nuwagaba-Biribonwoha H; Saito S; Horowitz D; Nash D; Mugabo J; Mugisha V; Rugigana E; Nkunda R; Asiimwe A
    PLoS One; 2013; 8(1):e53586. PubMed ID: 23326462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
    Nsanzimana S; Remera E; Kanters S; Forrest JI; Ford N; Condo J; Binagwaho A; Bucher H; Thorlund K; Vitoria M; Mills EJ
    Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
    Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2014 Apr; 26(4):448-53. PubMed ID: 24215157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of viral load monitoring and viral suppression under Treat All in Rwanda - a cross-sectional study.
    Ross J; Ribakare M; Remera E; Murenzi G; Munyaneza A; Hoover DR; Shi Q; Nsanzimana S; Yotebieng M; Nash D; Anastos K;
    J Int AIDS Soc; 2020 Jun; 23(6):e25543. PubMed ID: 32536033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
    Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
    Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
    Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
    PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Viral Suppression Among a Cohort of Adolescents and Young Adults with Behaviorally Acquired Human Immunodeficiency Virus.
    Wood SM; Lowenthal E; Lee S; Ratcliffe SJ; Dowshen N
    AIDS Patient Care STDS; 2017 Sep; 31(9):377-383. PubMed ID: 28891717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.
    Coffey S; Bacchetti P; Sachdev D; Bacon O; Jones D; Ospina-Norvell C; Torres S; Lynch E; Camp C; Mercer-Slomoff R; Lee S; Christopoulos K; Pilcher C; Hsu L; Jin C; Scheer S; Havlir D; Gandhi M
    AIDS; 2019 Apr; 33(5):825-832. PubMed ID: 30882490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana.
    Obiri-Yeboah D; Pappoe F; Baidoo I; Arthur F; Hayfron-Benjamin A; Essien-Baidoo S; Kwakye-Nuako G; Ayisi Addo S
    BMC Infect Dis; 2018 May; 18(1):230. PubMed ID: 29783953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-Based Accompaniment Mitigates Predictors of Negative Outcomes for Adults on Antiretroviral Therapy in Rural Rwanda.
    Gupta N; Munyaburanga C; Mutagoma M; Niyigena JW; Kayigamba F; Franke MF; Hedt-Gauthier B
    AIDS Behav; 2016 May; 20(5):1009-16. PubMed ID: 26346334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.